Sage Journals: Discover world-class research

Abstract

Children are put at unnecessary risk in everyday clinical practice by being given medicines whose safety and efficacy have not been adequately researched.

The lack of appropriate dosage forms for many ‘essential medicines’ for the main five treatable conditions causing the deaths of 10 million children worldwide under the age of 5 years are a major reason why countries are not achieving their millennium developmental goals.

There has been understandable reluctance to undertake the necessary research on children. The reasons for this are reviewed. The existing levels of protection for child subjects worldwide are insufficient. Key principles are suggested both to encourage clinical research and to ensure adequate protection for children around the world.

Get full access to this article

View all access options for this article.

References

Seyberth

, Demotes-Mainard

, Wrobel

. Developing a European framework for research on children's medicines. Paediatr Nephrol 2005; 20: 1537–40

AAP Committee on Drugs. Unapproved Uses of Approved Drugs: The Physician, the Package Insert, and the Food and Drug Administration: Subject Review. Pediatrics 1996; 98: 143–5

Additional Safeguards for Children in Clinical Investigations Section 50.50–56. Food and Drug Administration, 2007. See http://www.fda.gov/

Gill

; Ethics Working Group of the Confederation of European Specialists in Paediatrics. Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the Ethics Working Group of the Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr 2004; 163: 53–7

Better Medicines for Children. World Health Organization Sixtieth World Health Assembly, 2007

Child Health Research: A Foundation for Improving Child Health. WHO/FCH/CAH/02.3. Geneva: World Health Organization, 2002

United Nations Children's Fund. The State of the World's Children 2008. New York, NY: UNICEF, 2007

World Medical Assocation Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Ferney-Voltaire: World Medical Association, 2004 (revised). See http://www.wma.net/e/policy/b3.htm

10.

MRC Ethics Guide. Medical research involving children. London: MRC, 2004. See http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002430

11.

ICH Steering Committee. ICH Harmonised Tripartite Guideline. Clinical Investigation of Medicinal Products in the Paediatric Population E11. Geneva: ICH, 2000. See www.ich.org/MediaServer.jser?@_ID=487&@_MODE=GLB

12.

Appleyard

. Medical research on child subjects. World Med J 2007; 53: 87–90

13.

The National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research. Ethical Principles and Guidelines for the protection of human subjects of research. DHEW Publication No 78-00 (OS). Washington, DC: Department of Health, Education, and Welfare, 1979 [The Department of Health, Education, and Welfare is now the Department of Health and Human Services]

14.

Appleyard

. Who cares? The Declaration of Helsinki and ‘The conscience of physicians’. Research Ethics Review 2008; 3: 106–11

15.

Krugman

. Experiments at the Willowbrook State School. Lancet 1971; 1: 966–7

16.

Choonara

. Regulation of drugs for children in Europe. BMJ 2007; 335: 1221–2

Risks and benefits of research on children: developing an ethical framework to meet children's needs

Abstract

Get full access to this article

References